Sophonix MS-Fast Analyzer
 

Sophonix MS-Fast

Automated Chemiluminescent Immunoassay Analyzing System

for detection of COVID-19 antibodies

Sophonix MS-Fast is a fully automatic chemiluminescence immunoassay analyzing system that, when used in combination with the BioCheck SARS-CoV-2 IgM and IgG Antibody Test kits, can qualitatively detect the content of SARS-CoV-2 IgM and IgG antibodies in human serum samples.

The Sophonix MS-Fast analyzer and BioCheck SARS-CoV-2 Antibody Test kits are for in vitro diagnostic use in the United States under FDA Emergency Use Authorization.

Product Features

Instrument runtime: : approx. 30 minutes

Throughput/Capacity: up to 8 samples per run

Scalable, affordable benchtop model

Excellent specificity and sensitivity compared to ELISA and lateral flow tests

 

Get Answers Have questions about our COVID-19 products? Get Answers

SARS-COV-2 IgG and IgM

SARS-COV-2 IgM and IgG

The BioCheck SARS-CoV-2 IgM and IgG Antibody Test kits use chemiluminescent immunoassays to qualitatively detect the content of SARS-CoV-2 IgM and IgG antibodies in human serum samples.

Learn about BioCheck SARS-CoV-2 tests

Chemiluminescence

The analyzer uses indirect chemiluminescence based on chemiluminescent substrate (APS-5) and alkaline phosphatase, and is used together with the supporting detection reagents in the BioCheck SARS-CoV-2 tests to detect IgM and IgG antibodies that confirm exposure and indicate potential immunity to COVID-19.

Accelerate Diagnostics distributes the Sophonix MS-Fast system and BioCheck SARS-CoV-2 tests.

Specifications

Instrument type

Automated chemiluminescent immunoassay analyzing system

Model

MS-Fast

Size

20in (W) x 23.1in (D) x 13.5in (H)

Weight

88 lbs (40 kg)

Printer

Built in

Computer

Built in

Screen

7in LCD touch screen (800×600)

Operating System

Microsoft Windows 10

Electrical Requirements

110-220VAC

Rated Power Supply

110-220V / 50-60HZ / 200W

Detection Batch

8-channel parallel detection, free to combine items

Sample Material

Serum

Detection Principle

Chemiluminescence enzyme-linked immunosorbent assay (CLEIA) and magnetic particle separation technology

Sample Volume

80μL of serum for the IgM/IgG tests

Wavelength

300-650nm

Data Storage

Patient data: more than 100,000 samples (tests)

IMPORTANT INFORMATION:

  • This test has not been FDA cleared or approved;
  • This test has been authorized by FDA under an Emergency Use Authorization for use by authorized laboratories;
  • This test has been authorized only for the presence of IgG and IgM antibodies against SARS-CoV-2, not for any other viruses or pathogens; and
  • This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Ordering MS-Fast

Accelerate Diagnostics distributes the Sophonix MS-Fast analyzer and BioCheck SARS-CoV-2 tests in North America.

The Sophonix MS-Fast Analyzer and BioCheck SARS-CoV-2 IgM and IgG Antibody Test Kits are for in vitro diagnostic use in the United States under FDA Emergency Use Authorization.

US Product Number: T-1001

Customers outside the US: contact us for more information.
Order your MS-Fast analyzer